Literature DB >> 22810119

Lesional infiltration of receptor activator of nuclear factor-κB ligand⁺ cells in experimental autoimmune neuritis rats.

Ying Yin1, Hermann J Schluesener, Zhi-Yuan Zhang, Zhiren Zhang.   

Abstract

Experimental autoimmune neuritis (EAN) is a T cell-mediated autoimmune demyelinating inflammatory disease of the peripheral nervous system. Receptor activator of NF-κB ligand (RANKL), a member of the tumor necrosis factor family, regulates proliferation of mature T cells. Here, we have studied the expression of RANKL in sciatic nerves of EAN rats. EAN was induced in male Lewis rats. The spatiotemporal expression of RANKL in sciatic nerves of EAN rats was investigated using immunohistochemistry. In sciatic nerves of normal rats RANKL(+) cells were rarely seen. EAN induced a significant accumulation of RANKL(+) cells in sciatic nerves and there was a significant positive correlation of the time course of RANKL(+) cell accumulations with neurological scores of EAN rats. The major cellular resources of RANKL in sciatic nerves were T cells and macrophages. The positive association of RANKL(+) cell accumulations with neurological scores of EAN rats together with the known functions of RANKL indicated that RANKL might play a role in pathologic development of EAN and need further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22810119     DOI: 10.1007/s10072-012-1154-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

Review 1.  New paradigm of gene therapy: skeletal-muscle-targeting gene therapy for kidney disease.

Authors:  E Imai; Y Isaka
Journal:  Nephron       Date:  1999       Impact factor: 2.847

2.  In vitro characterization of mesenchymal stem cell-seeded collagen scaffolds for tendon repair: effects of initial seeding density on contraction kinetics.

Authors:  H A Awad; D L Butler; M T Harris; R E Ibrahim; Y Wu; R G Young; S Kadiyala; G P Boivin
Journal:  J Biomed Mater Res       Date:  2000-08

Review 3.  Balancing protective immunity and immunopathology.

Authors:  Martin F Bachmann; Manfred Kopf
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

4.  RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.

Authors:  Teruji Totsuka; Takanori Kanai; Yasuhiro Nemoto; Takayuki Tomita; Ryuichi Okamoto; Kiichiro Tsuchiya; Tetsuya Nakamura; Naoya Sakamoto; Hisaya Akiba; Ko Okumura; Hideo Yagita; Mamoru Watanabe
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

5.  Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women.

Authors:  W S Browner; L Y Lui; S R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 6.  Do RANKL inhibitors (denosumab) affect inflammation and immunity?

Authors:  S Ferrari-Lacraz; S Ferrari
Journal:  Osteoporos Int       Date:  2010-06-23       Impact factor: 4.507

7.  TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells.

Authors:  R Josien; B R Wong; H L Li; R M Steinman; Y Choi
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

8.  Expression of interleukin-16 in sciatic nerves, spinal roots and spinal cords of experimental autoimmune neuritis rats.

Authors:  Zhi-Yuan Zhang; Zhiren Zhang; Uwe Fauser; Hermann J Schluesener
Journal:  Brain Pathol       Date:  2008-05-06       Impact factor: 6.508

9.  Chronic regenerative changes in the spinal cord after cord compression injury in rats.

Authors:  M C Wallace; C H Tator; A J Lewis
Journal:  Surg Neurol       Date:  1987-03

10.  Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats.

Authors:  Joanna M Lubieniecka; Femke Streijger; Jae H T Lee; Nikolay Stoynov; Jie Liu; Randy Mottus; Tom Pfeifer; Brian K Kwon; Jens R Coorssen; Leonard J Foster; Thomas A Grigliatti; Wolfram Tetzlaff
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.